NutriFactGuide | Evidence-based supplement and nutrition guide

Medical disclaimer: This article is for education only and is not medical advice. Erectile dysfunction can signal serious underlying conditions, and prescription drugs and supplements can interact. Talk to a doctor or pharmacist before starting, stopping or combining anything mentioned here.

Key takeaways

• Sildenafil is a prescription PDE5 inhibitor with large, well-designed trials behind it. It is a first-line treatment for erectile dysfunction (ED) in guidelines worldwide.

• L-arginine is an amino acid supplement. Evidence is smaller and mixed: some trials show benefit, mostly in mild-to-moderate ED, and others show no benefit over placebo.

• A 2021 meta-analysis of randomized trials concluded that PDE5 inhibitors alone worked better than L-arginine alone, and that combining the two improved results without a clear increase in side effects [7].

• Sildenafil's common side effects (headache, flushing, indigestion, nasal congestion, visual changes) are usually mild. It must never be combined with nitrate medicines.

• L-arginine is usually well tolerated at studied doses, but it can lower blood pressure and cause digestive upset. A 2006 trial found a possible increase in deaths when it was given to people recovering from a heart attack [9].

What is erectile dysfunction?

Erectile dysfunction is the persistent or recurrent inability to achieve or maintain an erection firm enough for satisfactory sexual activity. It is common, becomes more frequent with age, and is not simply an "older man's problem" or a purely psychological one.

An erection is a blood-flow event controlled by nerves, hormones, blood vessels and the mind. During sexual stimulation, nerve endings and the cells lining penile blood vessels release nitric oxide (NO). NO triggers production of a messenger molecule called cyclic GMP (cGMP), which relaxes smooth muscle in the penile arteries and erectile tissue. Blood rushes in and is trapped, producing an erection. An enzyme called phosphodiesterase type 5 (PDE5) breaks cGMP down again, ending the erection.

That pathway explains both treatments in this article. Sildenafil blocks PDE5, so cGMP lasts longer. L-arginine is the raw material the body uses to make NO, so supplementing it is meant to feed the start of the same pathway.

Common causes and risk factors include:

• Vascular disease and high blood pressure

• Type 2 diabetes

• High cholesterol and obesity

• Smoking and heavy alcohol use

• Low testosterone or other hormonal problems

• Nerve damage, including after pelvic or prostate surgery

• Some prescription medicines

• Stress, anxiety, depression and relationship problems

Because ED often shares causes with heart and blood vessel disease, it is worth a proper medical check-up and not only a supplement or pill.

Sildenafil: uses and how it works

Sildenafil citrate was developed by Pfizer and approved by the US FDA in 1998 as the first oral drug for ED. It is now also available as generics. A different formulation and dose of sildenafil is used for pulmonary arterial hypertension, which is a separate medical use.

How it works. Sildenafil is a selective inhibitor of PDE5, the enzyme that breaks down cGMP in the erectile tissue. Pharmacology reviews note that it has no effect without sexual stimulation, and that it is absorbed quickly, with peak blood levels reached 30 to 120 minutes after a dose taken fasting. Its absolute bioavailability is about 40%, and it is cleared mainly by the liver enzyme CYP3A4 [4].

Typical use. Doctors prescribe it on an as-needed basis, taken before sexual activity, in doses of 25 mg, 50 mg or 100 mg. It is not a daily "booster" and does not create desire. Dose and suitability depend on age, other medicines, and liver and kidney function, so it should be prescribed and supervised by a clinician.

What the studies show for sildenafil

The landmark trial was published in the New England Journal of Medicine in 1998 by Goldstein and colleagues. In a 24-week dose-response study, 532 men with ED of organic, psychogenic or mixed causes received 25, 50 or 100 mg of sildenafil or placebo. Higher doses produced progressively better erectile function scores. In a second dose-escalation study, 69% of intercourse attempts were successful in men taking sildenafil, compared with 22% in the placebo group. Men on sildenafil had about 5.9 successful attempts per month versus 1.5 on placebo [1].

Since then, the drug has been studied in hundreds of trials, including men with diabetes, hypertension and spinal cord injury. A systematic review of randomized trials published in the British Journal of General Practice concluded that sildenafil is an effective treatment for male ED [2].

L-arginine: uses and how it works

L-arginine is a "semi-essential" amino acid. The body makes some of it, and the rest comes from foods such as meat, fish, dairy, nuts and seeds. It is the substrate that nitric oxide synthase enzymes convert into NO, which is why it became a popular ED supplement.

Typical supplement doses. Trials of oral L-arginine for ED have used roughly 1.5 to 6 grams per day, often split across the day, for periods from a couple of weeks to three months. Commercial products frequently combine it with other ingredients such as Pycnogenol (pine bark extract), ginseng or citrulline, which makes it harder to know what is doing the work.

Why it may not work as expected. Providing more raw material only helps if a shortage of arginine or NO is the limiting problem. Oral arginine is also partly broken down in the gut and liver before it reaches the circulation. In many men with ED, the real issue is damaged blood vessel lining, nerve injury or hormonal imbalance, which extra arginine does not fix.

What the studies show for L-arginine

Results are genuinely mixed, and that is the honest summary.

Early trials with different outcomes:

• Chen et al., 1999 (BJU International). Fifty men with organic ED were randomized after a placebo run-in to 5 g/day of L-arginine or placebo for 6 weeks. Nine of 29 men on arginine (31%) and 2 of 17 on placebo reported significant subjective improvement. All nine responders had low baseline urinary NO metabolites, which roughly doubled during treatment. Objective penile blood-flow measurements did not change. The authors concluded that benefit seemed limited to men with reduced NO production [3].

• Klotz et al., 1999 (Urologia Internationalis). In a crossover study of 32 men with mixed-type ED, 3 x 500 mg of L-arginine per day was compared with placebo. Five men (17%) improved significantly on arginine and six (20%) on placebo. The authors concluded that this dose was not better than placebo as first-line treatment [5].

More recent, higher-dose research:

• Menafra et al., 2022 (Journal of Endocrinological Investigation). This multicentre, double-blind, placebo-controlled trial randomized 98 men with vasculogenic ED to 6 g/day of L-arginine (51 men) or placebo (47 men) for three months. The median IIEF-6 score (a standard six-question erectile function questionnaire) rose from 20 to 24 in the arginine group and was unchanged in the placebo group. By the end, 24% of men on arginine had no ED by IIEF-6 criteria versus about 2% on placebo. Benefit was clearer in mild-to-moderate ED; in severe ED, the questionnaire score improved but penile blood-flow velocity did not. The authors suggested arginine may be an option for mild-to-moderate cases in men who cannot take PDE5 inhibitors or have side effects from them [6].

• Type 2 diabetes trial. An Iranian double-blind trial in 80 men with type 2 diabetes and mild-to-moderate ED reported that 5 g/day of L-arginine for four weeks improved erectile function scores compared with placebo, along with some other sexual function measures [11]. It was a short, small study and should be considered preliminary.

Pooled analyses:

• Rhim et al., 2019 (Journal of Sexual Medicine). A meta-analysis found that arginine doses of 1,500 to 5,000 mg improved ED compared with placebo or no treatment (odds ratio 3.37, 95% CI 1.29 to 8.77), with improvements in erectile function and satisfaction scores. The authors concluded arginine could be considered for mild-to-moderate ED [8]. The wide confidence interval and small trials limit confidence in the size of the effect.

• Combination products. A 2023 meta-analysis in Frontiers in Endocrinology pooled three studies (184 patients) of L-arginine plus Pycnogenol and found improvements in erectile function scores, but called for larger trials [12].

Overall reading. L-arginine probably helps some men with mild-to-moderate, blood-flow-related ED, especially at higher doses taken for weeks to months, but the studies are small, vary in quality, and do not show it matches prescription drugs.

Head-to-head: sildenafil vs L-arginine

Few trials compare the two directly. The best summary comes from the 2021 meta-analysis in Andrologia, which pooled randomized trials of daily oral L-arginine, PDE5 inhibitors, and both together. It found that all three approaches improved erectile function from baseline, but that PDE5 inhibitors alone showed a better effect than L-arginine alone. The combination produced greater improvement in sexual function scores and total testosterone than either treatment alone, without a significant increase in adverse events [7]. Other reviews describe only a small number of trials combining arginine with a PDE5 inhibitor, so this finding is promising but not definitive [13].

Comparison table

Feature Sildenafil L-arginine

Type Prescription drug (PDE5 inhibitor) Amino acid dietary supplement

Regulatory status for ED Approved by FDA and other regulators Not approved for ED treatment

Mechanism Blocks PDE5, so cGMP and penile blood Supplies the production
vessel relaxation last longer

Needs sexual stimulation? Yes, works only with arousal Not applicable; taken regularly

How it is taken On demand, 25-100 mg, before sex Daily, about 1.5-6 g in studies, often divided

Onset Peak levels about 30-120 minutes
after dose Weeks of daily use in trials

Key efficacy evidenceLarge randomized trials; 69% vs 22%
successful intercourse attempts in a
pivotal trial [1] Small, mixed trials; benefit mainly in mild-to-moderate ED [3, 5, 6, 8]

Strength of evidence Strong Low to moderate

Works in severe ED? Often effective across severity levels Limited; questionnaire improvement but not blood flow in severe cases [6]

Most common side effects Headache, flushing, indigestion,
nasal congestion, visual changes Nausea, bloating, diarrhea, stomach cramps; possible low blood pressure

Serious cautions Never with nitrates; rare vision
loss (NAION) reports Avoid after heart attack; use caution with blood pressure drugs and nitrates

Needs a prescription? Yes No, but medical advice is wise

Quality control Regulated manufacturing Varies between supplement brands

Side effects of sildenafil

Sildenafil has been used by millions of men for more than 25 years, so its safety profile is well documented.

Common side effects

The US prescribing information lists the most common adverse reactions in flexible-dose clinical trials as headache (16% on sildenafil vs 4% on placebo), flushing (10% vs 1%), indigestion (7% vs 2%) and nasal congestion (4% vs 2%). Other reactions reported by at least 2% of men include abnormal vision, back pain, muscle aches, nausea, dizziness and rash [10]. The visual changes are usually mild and temporary, such as a bluish tinge to vision, light sensitivity or blurring, and are linked to a small effect on a related enzyme (PDE6) in the retina [10, 14].

A systematic review and meta-analysis of 49 placebo-controlled trials (Tsertsvadze et al., Urology, 2009) found that men on sildenafil were 56% more likely than those on placebo to report any adverse event. Risks were higher for flushing, indigestion, visual disturbances and headache, and they increased with dose. Serious adverse events and dropouts due to side effects were similar to placebo, though most trials lasted 12 weeks or less [15].

In long-term safety data from more than 3,700 patients, 90% of those in open-label extension studies completed long-term treatment, and only 2% withdrew because of side effects [16]. The US label also reports that discontinuation due to adverse reactions was about 2.5% with sildenafil versus 2.3% with placebo [10].

Rare but serious risks

• Nitrate interaction. Sildenafil is contraindicated with organic nitrates (such as nitroglycerin and isosorbide) because the combination can cause a sudden, dangerous drop in blood pressure [4]. This is the single most important safety rule.

• Vision loss (NAION). Non-arteritic anterior ischemic optic neuropathy has been reported rarely after PDE5 inhibitor use. An observational case-crossover study estimated about a 2-fold higher risk (2.15, 95% CI 1.06 to 4.34), but the label states that causation has not been established, and many affected men had other risk factors [17]. Anyone with sudden vision loss should stop the drug and seek urgent medical care.

• Sudden hearing changes. Post-marketing reports exist, though a direct causal link is unclear [10].

• Prolonged erection (priapism). Erections lasting more than four hours need emergency treatment. No cases were seen in the early clinical trial program [4].

• Drug interactions. Certain medicines, including some HIV drugs such as ritonavir, raise sildenafil levels, and combining it with alpha-blockers or other blood pressure drugs may cause dizziness or low blood pressure [10].

Who should be especially careful

Men with heart disease, low blood pressure, severe liver or kidney problems, prior vision loss in one eye, or those taking nitrates or multiple blood pressure medicines need a doctor's assessment before use. Sexual activity itself is also exertion, so heart health should be evaluated.

Side effects of L-arginine

L-arginine is found in food and is generally tolerated at the doses used in ED research, but "natural" does not mean risk-free.

Common side effects

The most commonly reported effects are digestive: nausea, stomach cramps, bloating and diarrhea, which tend to be dose-related and more likely with large single doses. Splitting the daily amount can help. Several ED trials reported few problems: in the Klotz crossover trial, no drug-related adverse effects occurred [5]. However, large, long-term safety studies in men with ED are lacking, so the safety record is much thinner than for sildenafil.

Blood pressure effects

Because L-arginine increases NO, it can relax blood vessels and lower blood pressure. This may cause lightheadedness, particularly in people already taking antihypertensive drugs, nitrates or other PDE5 inhibitors. Anyone on these medicines should ask a clinician first.

The heart attack warning

The most important safety signal comes from the VINTAGE MI trial, published in JAMA in 2006. It tested L-arginine (goal 3 g three times daily) against placebo for six months in 153 people after a first ST-elevation heart attack. The trial found no benefit on vascular stiffness or heart function, and six participants in the arginine group died, compared with none on placebo, so the safety committee closed enrollment. The authors concluded that L-arginine should not be recommended after acute myocardial infarction [9]. The result applies to a specific high-risk group, but it shows why cardiac patients should not self-prescribe arginine.

Other cautions

• People with kidney disease, liver disease, asthma or low blood pressure should check with a doctor first.

• Supplement quality varies, and ED products sold online often mix arginine with undeclared or unproven ingredients. Choose third-party-tested products and avoid "male enhancement" supplements that promise prescription-level results.

• Do not use arginine to replace medical evaluation of ED.

Can you take them together?

Some evidence says combining a PDE5 inhibitor with L-arginine gives a greater improvement than either alone, without a significant rise in side effects [7]. Still, both can lower blood pressure, and the number of high-quality trials is small. Never start the combination on your own, and tell your prescriber about any supplement you use.

Lifestyle and other treatments worth knowing

Supplements and pills work best alongside the basics. Regular exercise, a Mediterranean-style diet, weight loss if overweight, quitting smoking, limiting alcohol, good sleep and managing stress all improve vascular and sexual health. Treating diabetes, blood pressure and cholesterol matters because they drive ED. Other medical options include other PDE5 inhibitors (tadalafil, vardenafil, avanafil), testosterone treatment where deficiency is confirmed, vacuum devices, injections, and penile implants, as well as counselling for psychological causes.

When to see a doctor

• ED lasting more than a few weeks, or appearing suddenly

• Chest pain, breathlessness, or dizziness with exertion

• ED alongside diabetes, high blood pressure or heart disease

• Any plan to combine supplements with prescription drugs

• Sudden vision or hearing loss, or an erection lasting more than four hours after taking a PDE5 inhibitor (emergency)

The bottom line

If you want the treatment with the strongest evidence for erectile dysfunction, it is sildenafil or another PDE5 inhibitor, prescribed by a clinician. L-arginine is a reasonable topic for discussion with a doctor in mild-to-moderate ED, particularly at higher doses over weeks to months, but the research is small and inconsistent, and it should not be seen as a natural substitute for prescription treatment. Both options carry real cautions around blood pressure and heart health, and ED itself deserves a proper medical check.

References

1. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. https://pubmed.ncbi.nlm.nih.gov/9580646/

2. Systematic review of randomised controlled trials of sildenafil (Viagra) in the treatment of male erectile dysfunction. Br J Gen Pract. https://pmc.ncbi.nlm.nih.gov/articles/PMC1314170

3. Chen J, Wollman Y, Chernichovsky T, et al. Effect of oral administration of high-dose nitric oxide donor L-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study. BJU Int. 1999;83(3):269-273. doi:10.1046/j.1464-410x.1999.00906.x. https://pubmed.ncbi.nlm.nih.gov/10233492/

4. Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction. Clin Ther. 1998;20(6):1033-1048. doi:10.1016/s0149-2918(98)80103-3. https://pubmed.ncbi.nlm.nih.gov/9916601/

5. Klotz T, Mathers MJ, Braun M, Bloch W, Engelmann U. Effectiveness of oral L-arginine in first-line treatment of erectile dysfunction in a controlled crossover study. Urol Int. 1999;63(4):220-223. doi:10.1159/000030454. https://pubmed.ncbi.nlm.nih.gov/10743698/

6. Menafra D, de Angelis C, Garifalos F, et al. Long-term high-dose L-arginine supplementation in patients with vasculogenic erectile dysfunction: a multicentre, double-blind, randomized, placebo-controlled clinical trial. J Endocrinol Invest. 2022;45(5):941-961. doi:10.1007/s40618-021-01704-3. https://link.springer.com/article/10.1007/s40618-021-01704-3 (full text: https://pmc.ncbi.nlm.nih.gov/articles/PMC8995264/)

7. Comparison of efficacy and safety of daily oral L-arginine and PDE5Is alone or combination in treating erectile dysfunction: a systematic review and meta-analysis of randomised controlled trials. Andrologia. 2021;53(4):e14007. doi:10.1111/and.14007. https://pubmed.ncbi.nlm.nih.gov/33587304/

8. Rhim HC, Kim MS, Park Y-J, et al. The potential role of arginine supplements on erectile dysfunction: a systemic review and meta-analysis. J Sex Med. 2019;16(2):223-234. https://pubmed.ncbi.nlm.nih.gov/30770070/

9. Schulman SP, Becker LC, Kass DA, et al. L-arginine therapy in acute myocardial infarction: the VINTAGE MI randomized clinical trial. JAMA. 2006;295(1):58-64. doi:10.1001/jama.295.1.58. https://pubmed.ncbi.nlm.nih.gov/16391217/

10. Sildenafil (Viagra) US prescribing information, adverse reactions section (via DrugCentral). https://drugcentral.org/label/5cbac450-f336-45bd-8d10-9ecfd21866eb/view

11. Effect of oral supplementation of L-arginine on sexual function in men with type 2 diabetes: a double-blind clinical trial. https://jnfs.ssu.ac.ir/xml_out.php?a_id=76

12. Tian Y, Zhou Q, Li W, et al. Efficacy of L-arginine and Pycnogenol in the treatment of male erectile dysfunction: a systematic review and meta-analysis. Front Endocrinol. 2023. doi:10.3389/fendo.2023.1211720. https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1211720/full

13. Koolwal A, Manohar JS, Rao TSS, Koolwal GD. L-arginine and erectile dysfunction. J Psychosexual Health. 2019;1(1):37-43. doi:10.1177/2631831818822018. https://journals.sagepub.com/doi/reader/10.1177/2631831818822018

14. Azzouni F, Abu Samra K. Are phosphodiesterase type 5 inhibitors associated with vision-threatening adverse events? A critical analysis and review of the literature (summary). UroToday. https://www.urotoday.com/recent-abstracts/men-s-health/erectile-dysfunction/47671-beyond-the-abstract-are-phosphodiesterase-type-5-inhibitors-associated-with-vision-threatening-adverse-events-a-critical-analysis-and-review-of-the-literature-by-faris-azzouni-and-khawla-abu-samra.html

15. Tsertsvadze A, et al. Efficacy and safety of sildenafil in men with erectile dysfunction: systematic review and meta-analysis. Urology. 2009;74:831-836 (news summary: https://www.thedoctorschannel.com/view/long-term-risks-of-sildenafil-use-unclear-2)

16. Clinical safety of oral sildenafil citrate (Viagra) in the treatment of erectile dysfunction. Int J Impot Res. 1998;10:69-73. https://www.nature.com/articles/3900354.pdf

17. Sildenafil citrate prescribing information, warnings (NAION). https://medlibrary.org/lib/rx/meds/sildenafil-citrate-5/page/2/